Renafor-B

For inhalation only. The capsule should be placed in a dry powder inhaler device (e.g., Rotahaler) and the contents inhaled through the mouth. Do not swallow the capsule. Rinse mouth with water after each use to minimize the risk of oral candidiasis.

Budesonide is an anti-inflammatory corticosteroid that exhibits potent glucocorticoid activity and weak mineralocorticoid activity. It works by binding to glucocorticoid receptors in the airway cells, reducing the synthesis and release of inflammatory mediators like prostaglandins, leukotrienes, and cytokines. This leads to a decrease in airway inflammation, swelling, and mucus production, thus improving lung function and reducing symptoms of asthma and COPD.

• Acute bronchospasm or status asthmaticus (this medicine is not for rapid relief of acute symptoms).
• Hypersensitivity to Budesonide or any component of the formulation.
• Primary treatment of status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required.

Store below 30°C in a dry place, away from direct sunlight and moisture. Keep out of reach of children. Do not refrigerate or freeze.

Acute overdose with inhaled budesonide is unlikely to cause clinically significant problems. Chronic overdose may lead to signs and symptoms of hypercorticism, including adrenal suppression. Management includes gradual dose reduction and symptomatic treatment.

Pregnancy Category B. Studies in animals have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies in pregnant women. Budesonide is generally considered safe during pregnancy when benefits outweigh risks. Low levels are excreted in breast milk; however, the amount is unlikely to be harmful to the breastfed infant at therapeutic doses. Use with caution during lactation.

• Acute bronchospasm or status asthmaticus (this medicine is not for rapid relief of acute symptoms).
• Hypersensitivity to Budesonide or any component of the formulation.
• Primary treatment of status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required.

Store below 30°C in a dry place, away from direct sunlight and moisture. Keep out of reach of children. Do not refrigerate or freeze.

Acute overdose with inhaled budesonide is unlikely to cause clinically significant problems. Chronic overdose may lead to signs and symptoms of hypercorticism, including adrenal suppression. Management includes gradual dose reduction and symptomatic treatment.

Pregnancy Category B. Studies in animals have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies in pregnant women. Budesonide is generally considered safe during pregnancy when benefits outweigh risks. Low levels are excreted in breast milk; however, the amount is unlikely to be harmful to the breastfed infant at therapeutic doses. Use with caution during lactation.